Vancomycin-resistant Staphylococcus aureus:: no apocalypse now

被引：24

作者：

Goldstein, FW ^{[1
]}

Kitzis, MD ^{[1
]}

机构：

[1] St Joseph Hosp, Lab Microbiol Med, F-75014 Paris, France

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2003年 / 9卷 / 08期

关键词：

GISA; VRSA; vancomycin resistance; Staphylococcus aureus;

D O I：

10.1046/j.1469-0691.2003.00734.x

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The number of reports concerning vancomycin-resistant Staphylococcus aureus is much higher than the number of true resistant strains or unexpected clinical failures. Many confounding factors, including inadequate serum levels, severely ill patients, foreign devices or undrained abscesses, are more likely to be responsible for the clinical failures than resistance to vancomycin.

引用

页码：761 / 765

页数：5

共 30 条

[1] Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin
Ariza, J
Pujol, M
Cabo, J
Peña, C
Fernández, N
Liñares, J
Ayats, J
Gudiol, F
[J]. LANCET, 1999, 353 (9164) : 1587 - 1588
[2] DEVELOPMENT OF INVITRO RESISTANCE TO GLYCOPEPTIDE ANTIBIOTICS - ASSESSMENT IN STAPHYLOCOCCI OF DIFFERENT SPECIES
BIAVASCO, F
GIOVANETTI, E
MONTANARI, MP
LUPIDI, R
VARALDO, PE
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (01) : 71 - 79
[3] FAILURE OF TEICOPLANIN THERAPY IN 2 NEUTROPENIC PATIENTS WITH STAPHYLOCOCCAL SEPTICEMIA WHO RECOVERED AFTER ADMINISTRATION OF VANCOMYCIN
BRUNET, F
VEDEL, G
DREYFUS, F
VAXELAIRE, JF
GIRAUD, T
SCHREMMER, B
MONSALLIER, JF
[J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (02) : 145 - 147
[4] Glycopeptide-intermediate Staphylococcus aureus:: rediscovery of an old problem?
Cercenado, E
[J]. CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (10) : 517 - 518
[5] Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals
Chesneau, O
Morvan, A
El Solh, N
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 887 - 890
[6] Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin
Climo, MW
Patron, RL
Archer, GL
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1747 - 1753
[7] Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50
Cui, LZ
Murakami, H
Kuwahara-Arai, K
Hanaki, H
Hiramatsu, K
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) : 2276 - 2285
[8] CHARACTERIZATION OF STAPHYLOCOCCUS-AUREUS ISOLATES WITH DECREASED SUSCEPTIBILITY TO VANCOMYCIN AND TEICOPLANIN - ISOLATION AND PURIFICATION OF A CONSTITUTIVELY PRODUCED PROTEIN ASSOCIATED WITH DECREASED SUSCEPTIBILITY
DAUM, RS
GUPTA, S
SABBAGH, R
MILEWSKI, WM
[J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (05) : 1066 - 1072
[9] Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542
[10] Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital
Guerin, F
Buu-Hoï, A
Mainardi, JL
Kac, G
Colardelle, N
Vaupré, S
Gutmann, L
Podglajen, I
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (08) : 2985 - 2988

← 1 2 3 →